Revenue at Etihad Cargo increased 6% in the first half of 2022, contributing to 35% of Etihad Aviation Group’s operating revenue.
Premium products registered strong growth, with its pharmaceutical product, PharmaLife, seeing revenue increase 46%.
The PharmaLife product was enhanced with improved thermal covers to increase protection when loading and unloading cargo.
Revenue for the LiveAnimals product, for which Etihad Cargo was award IATA CEIV certification at the start of the year, was up 52%.
The Delivery as Promised rate was up 2% to 86% and the freighter On Time Performance rate was 83% despite challenging conditions.
Martin Drew, Senior Vice President Global Sales and Cargo at Etihad Aviation Group, says, “The growth Etihad Cargo has achieved across its PharmaLife and LiveAnimals products has been made possible by the hard work and commitment of dedicated teams that have thrived on the challenge of providing world-class cargo solutions to customers. Etihad Cargo's commitment to expanding capabilities has been demonstrated through the carrier's ongoing investment in infrastructure and solutions that ensure cargo is transported safely and in compliance with international standards.”
The electronic air waybill penetration rate was 81% as it invested in digitalisation. Its new online booking portal opened in 2021, with 57% more bookings via the portal.
A Mandarin version of its website and booking portal was launched, strengthening Etihad Cargo’s footprint in China, which contributes to over 20% of its operations.
Etihad Cargo has embarked on several sustainability projects including an agreement with B Medical Systems to develop and launch the industry’s first airline-specific passive temperature-controlled container units to transport pharmaceuticals.
The airline has replaced aluminium ULDs with environmentally friendly, lightweight ULDs, saving over 200 kilos, lowering fuel consumption and CO2 emissions.